FDA Advisory Panel Votes Down New Opioid Painkiller
An advisory panel for the U.S. Food and Drug Administration voted Tuesday not to recommend FDA approval of Australian drugmaker QRxPharma Ltd.'s painkiller Moxduo, the first drug to combine the opioids...To view the full article, register now.
Already a subscriber? Click here to view full article